The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

Autor: Marissa Meegdes, Khava I. E. Ibragimova, Dorien J. A. Lobbezoo, Ingeborg J. H. Vriens, Loes F. S. Kooreman, Frans L. G. Erdkamp, M. Wouter Dercksen, Birgit E. P. J. Vriens, Kirsten N. A. Aaldering, Manon J. A. E. Pepels, Linda M. H. van de Winkel, Jolien Tol, Joan B. Heijns, Agnes J. van de Wouw, Natascha A. J. B. Peters, Ananda Hochstenbach-Waelen, Marjolein L. Smidt, Sandra M. E. Geurts, Vivianne C. G. Tjan-Heijnen

Publikováno v: Breast Cancer Research and Treatment, 192(2), 331-342. Springer, Cham

Purpose The hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) are the main parameters in guiding systemic treatment choices in breast cancer, but can change during the disease course. This study aims to evaluate the biopsy rat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a5e909880f3c106d7fac4396b47579
https://doi.org/10.1007/s10549-021-06472-5

Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options

Autor: Michael J. Kerin, Catherine Curran, Carmel Malone, A. Ramli, Peter McAnena, Kevin Barry, James A. Brown, Andrew McGuire, Ray McLaughlin

Publikováno v: BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cancer

Background Recent studies have shown that breast cancer subtype can change from the primary tumour to the recurrence. Discordance between primary and recurrent breast cancer has implications for further treatment and ultimately prognosis. The aim of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75859f0bbf66715d0526aa5ca31b0397
https://doi.org/10.1186/s12885-018-4101-7

Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient

Autor: P van der Groep, J. E. Boers, Pieter Wesseling, Jelle Wesseling, Laurien D.C. Hoefnagel, M.J. van de Vijver, E. van der Wall, P. J. Van Diest

Publikováno v: Annals of oncology, 24(12), 3017-3023. Oxford University Press
Hoefnagel, L D C, van der Groep, P, van de Vijver, M J, Boers, J E, Wesseling, P, Wesseling, J, van der Wall, E & van Diest, P J 2013, ' Discordance in ER alpha, PR and HER2 receptor status across different distant breast cancer metastases within the same patient ', Annals of Oncology, vol. 24, no. 12, pp. 3017-3023 . https://doi.org/10.1093/annonc/mdt390
Annals of Oncology, 24(12), 3017-3023. Oxford University Press
Annals of Oncology, 24, 3017-23
Annals of Oncology, 24, 12, pp. 3017-23

Item does not contain fulltext BACKGROUND: We studied discordance in estrogen receptor alpha (ERalpha), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status between multiple distant metastases from the same breast can

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dcb7eb56960cbfcaacb48130608689f
https://doi.org/10.1093/annonc/mdt390

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.